Azitra Inc. is seeking a full-time Chief Scientist to lead the company’s research in microbiome-based therapeutics for treating skin diseases. Azitra’s lead candidate, AZT-01, is a recombinant strain of a safe, commensal skin bacterium that secretes therapeutic proteins for the treatment of skin disease. Integration of microbiomics, synthetic biology, and protein engineering is essential for the success of the company.